Synergic fabrication of dual drug-loaded polymeric nanoparticles system to improve the in vitro treatment of glioma metastasis specific targeting therapy

References

• Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75(1):5–11. doi: 10.1007/s11060-004-8093-6
   PubMed Web of Science ®Google Scholar
• Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers. 2015;1(1):15017. doi: 10.1038/nrdp.2015.17
   PubMed Web of Science ®Google Scholar
• Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017;40(1):1–14. doi: 10.1007/s10143-016-0709-8
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Stetson L, et al. Epidemiology of gliomas. Cancer Treat Res. 2015;163:1–14. doi: 10.1007/978-3-319-12048-5_1
   PubMedGoogle Scholar
• Negahdari R, Bohlouli S, Sharifi S, et al. Therapeutic benefits of rutin and its nanoformulations. Phytother Res. 2021;35(4):1719–1738. doi: 10.1002/ptr.6904
   PubMed Web of Science ®Google Scholar
• Ganeshpurkar A, Saluja AK. The pharmacological potential of Rutin. Saudi Pharm J. 2017;25(2):149–164. doi: 10.1016/j.jsps.2016.04.025
   PubMed Web of Science ®Google Scholar
• Tongjaroenbuangam W, Ruksee N, Chantiratikul P, et al. Neuroprotective effects of quercetin, rutin and okra (abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem Int. 2011;59(5):677–685. doi: 10.1016/j.neuint.2011.06.014
   PubMed Web of Science ®Google Scholar
• Deepika MS, Thangam R, Sheena TS, et al. A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2019;109:1181–1195. doi: 10.1016/j.biopha.2018.10.178
   PubMed Web of Science ®Google Scholar
• Ghanbari-Movahed M, Mondal A, Farzaei MH, et al. Quercetin- and rutin-based nano-formulations for cancer treatment: a systematic review of improved efficacy and molecular mechanisms. Phytomedicine. 2022;97:153909. doi: 10.1016/j.phymed.2021.153909
   PubMed Web of Science ®Google Scholar
• Zeng X, Guo F, Ouyang D. A review of the pharmacology and toxicology of aucubin. Fitoterapia. 2020;140:104443. doi: 10.1016/j.fitote.2019.104443
   PubMed Web of Science ®Google Scholar
• Jin L, Xue HY, Jin LJ, et al. Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol. 2008;582(1–3):162–167. doi: 10.1016/j.ejphar.2007.12.011
   PubMed Web of Science ®Google Scholar
• Chang IM. Liver-protective activities of aucubin derived from traditional oriental medicine. Res Commun Mol Pathol Pharmacolresearch. 1998;102(2):189–204.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou XM, Wu LY, et al. Aucubin alleviates oxidative stress and inflammation via Nrf2-mediated signaling activity in experimental traumatic brain injury. J Neuroinflammation. 2020;17(1):188. doi: 10.1186/s12974-020-01863-9
   PubMed Web of Science ®Google Scholar
• Hung JY, Yang CJ, Tsai YM, et al. Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol. 2008;35(9):995–1001. doi: 10.1111/j.1440-1681.2008.04935.x
   PubMed Web of Science ®Google Scholar
• Gao ZX, Zhang ZS, Qin J, et al. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma. Phytomedicine. 2023;112:154715. doi: 10.1016/j.phymed.2023.154715
   PubMed Web of Science ®Google Scholar
• Paolicelli P, de la Fuente M, Sánchez A, et al. Chitosan nanoparticles for drug delivery to the eye. Expert Opin Drug Delivery. 2009;6(3):239–253. doi: 10.1517/17425240902762818
   PubMed Web of Science ®Google Scholar
• Garg U, Chauhan S, Nagaich U, et al. Current advances in Chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull. 2019;9(2):195–204. doi: 10.15171/apb.2019.023
   PubMed Web of Science ®Google Scholar
• Caraway CA, Gaitsch H, Wicks EE, et al. Polymeric nanoparticles in brain cancer therapy: a review of Current approaches. Polymers. 2022;14(14):2963. doi: 10.3390/polym14142963
   PubMed Web of Science ®Google Scholar
• Saleh A, ElFayoumi HM, Youns M, et al. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. Naunyn-Schmiedeberg’s Arch Pharmacol. 2019;392(2):165–175. doi: 10.1007/s00210-018-1579-0
   Google Scholar
• Li Q, Ren L, Zhang Y, et al. P38 signal transduction pathway has more cofactors on apoptosis of SGC-7901 gastric cancer cells induced by combination of rutin and oxaliplatin. Bio Med Res Int. 2019;2019:6407210. doi: 10.1155/2019/6407210
   Google Scholar
• Satari A, Amini SA, Raeisi E, et al. Synergetic impact of combined 5-fluorouracil and Rutin on Apoptosis in PC3 cancer cells through the modulation of P53 gene expression. Adv Pharm Bull. 2019;9(3):462–469. doi: 10.15171/apb.2019.055
   PubMed Web of Science ®Google Scholar
• Farheen MS, Akhter MH, Chitme H, et al. Surface-modified biobased polymeric nanoparticles for dual delivery of doxorubicin and gefitinib in glioma cell lines. ACS Omega. 2023;8(31):28165–28184. doi: 10.1021/acsomega.3c01375
   PubMed Web of Science ®Google Scholar
• Sadreddini S, Safaralizadeh R, Baradaran B, et al. Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer. Immunol Lett. 2017;181:79–86. doi: 10.1016/j.imlet.2016.11.013
   PubMed Web of Science ®Google Scholar
• Alomari S, Zhang I, Hernandez A, et al. Drug repurposing for glioblastoma and current advances in drug delivery-a comprehensive review of the literature. Biomolecules. 2021;11(12):1870. doi: 10.3390/biom11121870
   PubMed Web of Science ®Google Scholar
• Wu Y, Qian Y, Peng W, et al. Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells. PeerJ. 2023;11:e15571. doi: 10.7717/peerj.15571
   PubMed Web of Science ®Google Scholar
• Zhang F, Xu CL, Liu CM. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma. Drug Design Develop Therapy. 2015;9:2089–2100. doi: 10.2147/DDDT.S79592
   PubMed Web of Science ®Google Scholar
• Lefranc F, Sadeghi N, Camby I, et al. Present and potential future issues in glioblastoma treatment. Expert Rev Anticancer Ther. 2006;6(5):719–732. doi: 10.1586/14737140.6.5.719
   PubMed Web of Science ®Google Scholar
• Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004;3(5):430–446. doi: 10.1038/nrd1380
   PubMed Web of Science ®Google Scholar
• Roque D, Cruz N, Ferreira HA, et al. Nanoparticle-Based Treatment in Glioblastoma. J Pers Med. 2023;13(9):1328. doi: 10.3390/jpm13091328
   PubMed Web of Science ®Google Scholar
• Patel D, Wairkar S, Yergeri MC. Current developments in targeted drug delivery systems for glioma. Curr Pharm Des. 2020;26(32):3973–3984. doi: 10.2174/1381612826666200424161929
   PubMed Web of Science ®Google Scholar
• Mahmoud BS, AlAmri AH, McConville C. Polymeric nanoparticles for the treatment of malignant gliomas. Cancers (Basel). 2020;12(1):175. doi: 10.3390/cancers12010175
   PubMed Web of Science ®Google Scholar
• Norouzi M, Yathindranath V, Thliveris JA, et al. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep. 2020;10(1):11292. doi: 10.1038/s41598-020-68017-y
   PubMed Web of Science ®Google Scholar
• Imani A, Maleki N, Bohlouli S, et al. Molecular mechanisms of anticancer effect of rutin. Phytotherapy Research. 2020;35(5):2500–2513. Advance online publication. doi: 10.1002/ptr.6977
   PubMed Web of Science ®Google Scholar
• Shao M, Kuang Z, Wang W, et al. Aucubin Exerts Anticancer Activity in Breast Cancer and Regulates Intestinal Microbiota. Evid Based Complement Alternat Med. 2022;2022:1–10. doi: 10.1155/2022/4534411
   Web of Science ®Google Scholar
• Williams GH, Stoeber K. The cell cycle and cancer. J Pathol. 2012;226(2):352–364. doi: 10.1002/path.3022
   PubMed Web of Science ®Google Scholar
• Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153–166. doi: 10.1038/nrc2602
   PubMed Web of Science ®Google Scholar
• Huo M, Xia A, Cheng W, et al. Rutin promotes pancreatic cancer cell apoptosis by upregulating miRNA-877-3p expression. Molecules (Basel, Switzerland). 2022;27(7):2293. doi: 10.3390/molecules27072293
   PubMed Web of Science ®Google Scholar
• Khan F, Pandey P, Jha NK, et al. Rutin mediated apoptotic cell death in Caski cervical cancer cells via notch-1 and hes-1 Downregulation. Life (Basel). 2021;11(8):761. doi: 10.3390/life11080761
   PubMed Web of Science ®Google Scholar
• Pandey P, Khan F, Alzahrani FA, et al. A novel approach to unraveling the apoptotic potential of rutin (bioflavonoid) via targeting Jab1 in cervical cancer Cells. Molecules (Basel, Switzerland). 2021;26(18):5529. doi: 10.3390/molecules26185529
   PubMed Web of Science ®Google Scholar
• Chen H, Miao Q, Geng M, et al. Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Sci World J. 2013;2013:1–8. doi: 10.1155/2013/269165
   Google Scholar
• Khan F, Pandey P, Upadhyay TK, et al. Anti-cancerous effect of rutin against HPV-C33A cervical cancer cells via G0/G1 Cell Cycle Arrest and apoptotic induction. Endocrine, Metabolic & Immune Disorders Drug Targets. 2020;20(3):409–418. doi: 10.2174/1871530319666190806122257
   PubMed Web of Science ®Google Scholar
• Wang R, Sun Y, Huang H, et al. Rutin, a natural flavonoid protects PC12 cells against sodium nitroprusside-induced neurotoxicity through activating PI3K/Akt/mTOR and ERK1/2 pathway. Neurochem Res. 2015;40(9):1945–1953. doi: 10.1007/s11064-015-1690-2
   PubMed Web of Science ®Google Scholar
• Chang C, Zhang L, Miao Y, et al. Anticancer and apoptotic-inducing effects of rutin-chitosan nanoconjugates in triple negative breast cancer cells. J Clust Sci. 2021;32(2):331–340. doi: 10.1007/s10876-020-01792-w
   Web of Science ®Google Scholar
• Ma B, Zhang J, Zhu Z, et al. Aucubin, a natural iridoid glucoside, attenuates oxidative stress-induced testis injury by inhibiting JNK and CHOP activation via Nrf2 up-regulation. Phytomedicine. 2019;64:153057. doi: 10.1016/j.phymed.2019.153057
   PubMed Web of Science ®Google Scholar
• Li YC, Hao JC, Shang B, et al. Neuroprotective effects of aucubin on hydrogen peroxide-induced toxicity in human neuroblastoma SH-SY5Y cells via the Nrf2/HO-1 pathway. Phytomedicine. 2021;87:153577. doi: 10.1016/j.phymed.2021.153577
   PubMed Web of Science ®Google Scholar
• Paudel KR, Wadhwa R, Tew XN, et al. Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Life Sci. 2021;276:119436. doi: 10.1016/j.lfs.2021.119436
   PubMed Web of Science ®Google Scholar
• Ben Sghaier M, Pagano A, Mousslim M, et al. Rutin inhibits proliferation, attenuates superoxide production and decreases adhesion and migration of human cancerous cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2016;84:1972–1978. doi: 10.1016/j.biopha.2016.11.001
   PubMed Web of Science ®Google Scholar
• Chiang LC, Ng LT, Chiang W, et al. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of plantago species. Planta Med. 2003;69(7):600–604. doi: 10.1055/s-2003-41113
   PubMed Web of Science ®Google Scholar
• Dhanikula RS, Argaw A, Bouchard JF, et al. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol Pharmaceut. 2008;5(1):105–116. doi: 10.1021/mp700086j
   PubMed Web of Science ®Google Scholar
• Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Revi Biochem. 1994;63(1):601–637. doi: 10.1146/annurev.bi.63.070194.003125
   PubMedGoogle Scholar
• Bell RD, Sagare AP, Friedman AE, et al. Transport pathways for clearance of human Alzheimer’s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow And Metab. 2007;27(5):909–918. doi: 10.1038/sj.jcbfm.9600419
   PubMed Web of Science ®Google Scholar